InvestorsObserver
×
News Home

Do Traders Think Adial Pharmaceuticals Inc (ADIL) Can Keep Climbing Wednesday?

Wednesday, February 28, 2024 09:39 AM | InvestorsObserver Analysts

Mentioned in this article

Do Traders Think Adial Pharmaceuticals Inc (ADIL) Can Keep Climbing Wednesday?

Overall market sentiment has been down on Adial Pharmaceuticals Inc (ADIL) stock lately. ADIL receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bearish
Adial Pharmaceuticals Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ADIL!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ADIL Stock Today?

Adial Pharmaceuticals Inc (ADIL) stock has gained 26.37% while the S&P 500 is lower by -0.29% as of 9:38 AM on Wednesday, Feb 28. ADIL has risen $0.22 from the previous closing price of $0.85 on volume of 805,749 shares. Over the past year the S&P 500 is up 27.15% while ADIL is lower by -90.49%. ADIL lost -$5.61 per share in the over the last 12 months.

More About Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. Click Here to get the full Stock Report for Adial Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App